CD274 and non-small cell lung carcinoma: This first-in-humans study of 68Ga-NOTA-WL12, a low-molecular-weight peptide-derived imaging agent, demonstrates the feasibility and potential of quantifying PD-L1 levels in NSCLC with PET within a clinically viable time frame.